Lisa Wright - 27 Apr 2022 Form 4 Insider Report for Vericel Corp (VCEL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Apr 2022, 16:22:28 UTC
Prior SEC filing
03 Jun 2021
Next SEC filing
02 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Flynn, as Attorney-in-Fact for Lisa Wright

Key filing fact

Lisa Wright filed Form 4 for Vericel Corp (VCEL) on 29 Apr 2022.

Key facts

  • This page summarizes Lisa Wright's Form 4 filing for Vericel Corp (VCEL).
  • 4 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 29 Apr 2022, 16:22.

Change

  • Previous filing in this sequence was filed on 03 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCEL transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,351
Change %
Price
Shares after
2,351
Date
27 Apr 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCEL transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-2,351
Change %
-100%
Price
$0.000000*
Shares after
0
Date
27 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,351
Exercise price
Footnotes
F2, F3, F4
VCEL transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+2,600
Change %
Price
$0.000000
Shares after
2,600
Date
27 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,600
Exercise price
Footnotes
F2, F4, F5
VCEL transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+6,500
Change %
Price
$0.000000
Shares after
6,500
Date
27 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,500
Exercise price
$31.99
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on June 1, 2021.

Footnote F2

Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

Footnote F3

These RSUs vest 100% on the earlier of April 28, 2022 or the date of the first Annual Meeting of Stockholders following April 28, 2021. The first Annual Meeting of Stockholders occurred on April 27, 2022.

Footnote F4

No expiration date for this type of award.

Footnote F5

These RSUs vest 100% on the earlier of April 27, 2023 or the date of the first Annual Meeting of Stockholders following April 27, 2022.

Footnote F6

The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .